NASDAQ
EyePoint Pharmaceuticals, Inc. (EYPT) has a current ratio of 8.88x as of Monday, May 25, 2026. This represents a 25.39% increase compared to its 12-month average of 7.08x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.